CluePoints Appoints Andy Cooper as New Chief Executive Officer

CluePoints Appoints Andy Cooper as New Chief Executive Officer New CEO brings a combination of experience and drive as CluePoints rapidly scales its RBQM and Data Quality Oversight offerings

Inizio acquires Evolution Road, bolstering Evoke’s digital innovation and omnichannel offering

Icosagen Chooses Genedata Biologics to Digitalize Recombinant Antibody Discovery

Leading CRDMO implements market-leading platform to streamline its biotherapeutics discovery workflow and data exchange with biopharma customers

MultiCare Partners with IllumiCare to Offer Clinical Trials at Point-of-Care with Trials App

MultiCare Health System is the first to use the Illumicare Trials App in a clinical setting, streamlining clinical trial recruitment and increasing awareness among providers, patients and clinical research teams.

Digital Therapeutics Alliance and Curebase release publication setting the stage for a fit-for-purpose evidence standard for digital therapeutics (DTx)

Digital Therapeutics Alliance and Curebase release publication setting the stage for a fit-for-purpose evidence standard for digital therapeutics (DTx)

Tesis Biosciences Announces Proposed Study of Veterans and Civilians with Mild Traumatic Brain Injury

Tesis Biosciences Announces Proposed Study of Veterans and Civilians with Mild Traumatic Brain Injury - Company in preparation for formal FDA approval submission

New Draper Study Showcases Powerful New Way to Evaluate Kidney Toxicity

A new study by scientists at Draper adds to the toolbox researchers can use in understanding the biological processes underway in organ-chips. They discovered a new indicator of toxicity in kidney-chips.

ScyTek announces a new special stain kit, The Martius Scarlet Blue (MSB) Stain Kit.

Scytek Laboratories Inc - The Martius Scarlet Blue (MSB) stain kit is intended for use in the histological demonstration of fibrin, muscle, collagen, and erythrocytes. MSB is a reliable method of differentiating fresh and old fibrin clusters.

CATALOG Achieves Historic DNA Computing Milestone

Endor Labs Unveils New Research on Impact of Open Source Software on Supply Chain Security

Endor Labs—a startup taking on the issue of unsecured open source sprawl for healthcare institutions and organizations of every kind – released new research exploring the impact of open source software on supply chain security.

Inozyme Pharma Announces Peer-Reviewed Publication Revealing Increased Prevalence of ENPP1 Deficiency

Leading disease experts and Genomenon published an article titled “Estimation of ENPP1 Deficiency Genetic Prevalence Using a Comprehensive Literature Review and Population Databases” in the Orphanet Journal of Rare Diseases

Qlucore announces software upgrade to facilitate improved single cell data analysis

Qlucore, a leading provider of powerful visualization-based bioinformatics data analysis tools, announces an upgrade to its Qlucore Omics Explorer (QOE) software. The upgrade adds features and functionality for easier data import and analysis of single cell data.

Qlucore software used in new project to prevent cardiovascular diseases

Nasdaq First North-listed Qlucore, a leading provider of visualization-based software for research and companion diagnostics, will play an important role as one of five key partners in the OmegaPerMed project. The project aims to optimize treatment with omega-3 to prevent cardiovascular diseases (CVD).

BRIM Biotechnology receives FDA Orphan Drug Designation for BRM424 to treat neurotrophic keratitis

BRIM Biotechnology, Inc. ("BRIM," TPEx 6885) is pleased to announce that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for BRM424 in the treatment of neurotrophic keratitis.

PHASTAR Joins Oncology Development Programme (ODP2) to Accelerate Development of Novel Cancer Innovations

PHASTAR Joins Oncology Development Programme (ODP2) to Accelerate Development of Novel Cancer Innovations London, UK and Durham, NC – 08 December, 2022 – PHASTAR, a global specialist biometrics contract research organization (CRO), has joined Lean Life Science’s Oncology Development Programme (ODP2). The targeted programme aims to identify and accelerate novel oncology innovations into commercially-attractive assets by offering support to academics and early-stage companies.

Verana Health and the American Academy of Ophthalmology Launch the Verana Research Network, an IRIS Registry Initiative

Partnership seeks to increase clinical trials access, accelerate recruitment, and advance ophthalmic research

PHASTAR Launches Pro-Bono Scheme for Charities

PHASTAR, a global specialist biometrics contract research organization (CRO), has announced the launch of a pro-bono scheme to give charities access to its volunteer statisticians, data scientists, data managers and programmers at no cost.

Cinchy Scores 5/5 For Product Vision Criterion In Major Enterprise Data Fabric Report

Cinchy was rated ‘best product vision’ in the Forrester Wave for Enterprise Data Fabric, receiving the highest score in that category. The company is on a mission to simplify the way the world works with data. It streamlines the way data’s managed, accessed and used by organizations, and enables them to regain control while collaborating securely in real-time through a single network of interconnected data. It pioneers dataware, a new technology category that can be thought of as the next tech revolution following hardware and software. This essentially frees data from applications – a major advance and breakaway from a 40-year technology norm that required data to be integrated with each new application a company builds, taking up to half of entire IT budgets. See more in the announcement: https://cinchy.com/news/cinchy-scores-5/5-for-product-vision-criterion-in-major-enterprise-data-fabric-report and please let me know if I can provide anything further. Thanks, Amanda Schweitzer amanda@cdc.agency (845) 453-0026

Recipharm announces extension of commercial manufacturing to support RedHill Biopharma’s Talicia® to 2026

Global contract development and manufacturing organization (CDMO) Recipharm, today announced an extension of the ongoing commercial manufacturing of RedHill Biopharma’s (Nasdaq: RDHL) drug, Talicia® for the treatment of H. pylori infection, to 2026.

Pharma and healthcare leaders discuss the innovations to fix our health system at Pharma Integrates 2022

With the UK’s health system under pressure, leaders and innovators from across pharma and healthcare gathered at London Tower Bridge to discuss the future of the sector at the 11th annual Pharma Integrates event.